ABM (Applied Biological Materials), founded in 2004, is a Canadian company, whose products are applied to the study and design of new drugs. The company focuses on the development of new, high-quality products at a reasonable price.
It has been catalysing scientific discovery in life sciences and drug development for more than 15 years. Headquartered in Vancouver, Canada, abm’s agility in developing and commercialising new research tools and its comprehensive portfolio of unique services have made it an invaluable partner to laboratories and research institutions around the world.
Driven by a team of passionate and talented scientists, ABM is dedicated to providing the scientific community with the latest innovations for life science research and drug development.
ABM’s broad offering includes
- RT-PCR,
- antibodies,
- siRNA,
- cell immortalisation,
- adenovirus,
- lentivirus and expression vectors.
ABM provides services to tailor its products to individual customer needs.
ABM’s mission is to help scientists leap to their next research milestone with game-changing products and services that optimise solutions and minimise costs. Its full range of products spans from CRISPR gene editing tools and viral vectors/viruses to the world’s largest collection of unique cell lines and the world’s most advanced PCR and next-generation sequencing technologies and services.
Consistently recognised as one of the 25 fastest growing companies in British Columbia, ABM has maintained exponential and sustainable growth year after year, with an average annual growth rate of 30% since incorporation. Today, ABM is proud to be one of the largest biotechnology companies in the region, contributing to the dynamic and fast-growing biotechnology sector in British Columbia.
You can read much more on our blog
